Why the study?
Does right atrial enlargement predict an increased risk of HF, stroke, systemic embolization, or death in patients with non-valvular atrial fibrillation?
Does right atrial enlargement predict an increased risk of HF, stroke, systemic embolization, or death in patients with non-valvular atrial fibrillation?
Right atrial enlargement serves as an independent predictor of adverse cardiovascular outcomes in patients with non-valvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
RA enlargement may refine prognostication in non-valvular AF; leaves open whether it should guide therapy.
RA enlargement was independently associated with an increased risk of HF, stroke, systemic embolization or death in patients with non-valvular AF, suggesting that RA volume can be helpful in assessing future cardiovascular risk in this population.
No takes yet. Share an insight, caveat, or question.
Ko et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: